Tissue And Organ Transplantation Market is Estimated to Expand its Size at a CAGR of 9.1% till 2027
Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Global Tissue and Organ Transplantation Market, by Product Type (Tissue Products, Preservation Solution, and Immunosuppressive Drugs), By Application (Organ Transplantation and Tissue Transplantation ), By End User (Hospital, Transplant Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 13.9 Billion in 2020 and is expected to exhibit a CAGR of 9.1% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.
Request for the trending sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/4342
High prevalence of chronic diseases such as diabetes, cancer, cardiovascular diseases, and renal diseases is expected to drive the market growth during the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC), 15% of adults in the U.S., accounting for 37 million people suffered from chronic kidney disease in 2019.
For instance, according to the World Health Organization, each year around 17.9 million people worldwide die due to Cardiovascular Diseases.
Tissue and Organ Transplantation Market – Impact of Coronavirus (Covid-19) Pandemic
Since December 2019, the novel coronavirus has spread throughout China and the world, with confirmed cases increasing within a short period of time. Moreover, the incidence and impact of coronavirus disease 2019 (COVID-19) has varied enormously across the globe. The pandemic has negatively impacted organ donation and transplantation in countries that have experienced high rates of infection, including the U.S., France, and the U.K., all reporting >50% reductions in transplant activity.
Quick Buy – Tissue and Organ Transplantation Market Research Report: https://www.coherentmarketinsights.com/insight/buy-now/4342
The coronavirus disease has badly affected ailing patients who are in need of organ transplants. The organ transplantation programme was temporarily suspended during the lockdown as a measure to avert the spread of COVID-19.
Patients with end-stage diseases- kidney, liver, heart, and lung failure, are worried following the COVID 19 pandemic. Although kidney failure patients can improve their health condition with continued dialysis, they are at a slightly higher risk of contracting COVID-19.
Key Takeaways of the Tissue and Organ Transplantation Market:
- The global tissue and organ transplantation market is expected to exhibit a CAGR of 9.1% during the forecast period (2020-2027), owing to increasing prevalence of diseases such as diabetes, cancer, cardiovascular diseases, renal diseases, and Alzheimer’s disease
- Major players operating in the global tissue and organ transplantation market include CryoLife, Inc., Folio Biosciences, Arthrex, Abbvie, Inc., Zimmer Biomet, Medtronic PLC, Novartis AG, Stryker Corporation, BiolifeSolutions, Inc., Teva Pharmaceuticals, and Veloxis Pharmaceutical.
Browse 35 Market Data Tables and 31 Figures spread through 220 Pages and in-depth TOC on Tissue and Organ Transplantation Market, by Product Type (Tissue Products Preservation Solution, and Immunosuppressive Drugs), By Application (Organ Transplantation and Tissue Transplantation ), By End User (Hospital, Transplant Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), – Forecast to 2027″
To know the latest trends and insights related to tissue and organ transplantation market press release, click the link below: https://www.coherentmarketinsights.com/press-release/tissue-and-organ-transplantation-market-3602
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Regulatory Scenario
- Impact Analysis
- PEST Analysis
- Porter’s Analysis
- Advancements in Technological Innovations
- Market Trends
- Growth in Transplant Tourism
- Key Developments
- Market Dynamics
- Tissue and Organ Transplantation Market – Impact of Coronavirus (Covid-19) Pandemic
- Supply-side Analysis
- Demand Side Analysis
- Impact on Healthcare Industry
- Global Tissue and Organ Transplantation Market, By Product Type, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Tissue Products
- Preservation Solution
- Immunosuppressive Drugs
- Introduction
- Global Tissue and Organ Transplantation Market, By Application, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Organ transplantation
- Tissue transplantation
- Introduction
- Global Tissue and Organ Transplantation Market, By End User, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospital
- Transplant Centers
- Others
- Introduction
- Global Tissue and Organ Transplantation Market, By Region, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, By Region, 2017 – 2027
- Regional Trends
- North America
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Middle East
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Introduction
- Competitive Landscape
- Company Profiles
- CryoLife, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Folio Biosciences
- Arthrex
- Abbvie, Inc.
- Zimmer Biomet
- Medtronic PLC
- Novartis AG
- Stryker Corporation
- BiolifeSolutions, Inc.
- Teva Pharmaceuticals
- Veloxis Pharmaceutical
- CryoLife, Inc.
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/4342
About Us:Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Editor Details
-
Company:
- CDN Newswire
